Alessandro Doria
Alessandro Doria
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease | Chronic Disease, Diabetes Complications, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, autoimmune disease, cardiovascular disorder, chronic renal failure syndrome, diabetes mellitus, diabetic kidney disease, endocrine system disorder, glucose metabolism disease, heart disorder, heart failure, immune system disorder, kidney disorder, kidney failure, metabolic disease, type 1 diabetes mellitus, urinary system disorder | Recruiting | Phase 3 | 2026-03-24 | NCT06217302 | |
| A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes | Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Diseases, autoimmune disease, diabetes mellitus, diabetic kidney disease, endocrine system disorder, glucose metabolism disease, immune system disorder, kidney disorder, metabolic disease, type 1 diabetes mellitus, urinary system disorder | Active, not recruiting | Phase 2 | 2026-02-06 | NCT04929379 |